The Imperial White City Incubator, Imperial College London's premiere science innovation centre, welcomes RebelBio, the world's first life sciences accelerator, to host its fifth cohort from the Incubator. This new partnership will help RebelBio launch its latest batch of 10 exciting companies which began in January 2018.
RebelBio, an accelerator fully owned by SOSV - The Accelerator VC, is committed to the funding & development of startups looking to change the world through the use of biology as a technology. The accelerator started operating in 2014 and has since invested in more than 40 companies. Previous graduates of the RebelBio accelerator include leaders in cellular agriculture Perfect Day Foods, Pili, Hexafly & MicrosynbiotiX.
RebelBio's latest batch of companies
AlgiKnit - Bio textiles for a sustainable future
Encelo Labs - Bringing genetic diversity into the the preclinical stage making personalised stem cell treatments more cost effective
VivoKey Technologies - Next generation blockchain enabled cryptobionics to improve security & the privacy of data
Chronomics - Epigenetic testing A.I platform to drive the future of personalised wellness
Corticare - A smart device for personalised, affordable, quick and accurate hormonal testing
Magellan Life Sciences - Using novel protein engineering & synthetic biology advances to address the global challenges of creating protein derived sweeteners
Visusnano - A novel medical device that will revolutionise cataract surgery & reduce surgical complications
Biomimetic Solutions - Developing scaffolds, bandages and nano-materials from 3D cell culture to produce organs and functional human tissue growth in vitro
Daekitech - Non invasive devices to diagnose and monitor chronic diseases, such as diabetes, with a disposable test strip that only uses saliva
Neurocreate - Neurofeedback and artificial intelligence, to augment human cognition and achieve 'Flow' neurological states for peak performance and stress alleviation
The ability to leverage Imperial's resources, including a close relationship to support companies, is a significant boost to SOSV’s already impressive global network of 600+ startups. In order to create advances in life sciences & healthcare, and solve global challenges, startups need to adapt and have access to cutting facilities & edge gene-editing tools. Support from ecosystem partners such as Clustermarket allow companies to get rapid access to expensive lab equipment & services at lower cost throughout the Golden Triangle also.
Steven O Connell, Associate Director & Programme Manager at RebelBio, said:
“We are excited to launch our first international cohort in the UK with Imperial Innovations at the White City Incubator, the leading support for coworking labs in the biotech field. We look forward to working together with Imperial and these innovative startups to broaden the scope of our support”